Want to see SE:IBT.B full AI Analyst Report?
Infant Bacterial Therapeutics AB (IBT.B) Income Statement
Infant Bacterial Therapeutics AB Income Statement
Last quarter (Q2 2026), Infant Bacterial Therapeutics AB's total revenue was $0.00. In Q2, Infant Bacterial Therapeutics AB's net income was $-29.73M. See Infant Bacterial Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 4.00K | $ 77.00K | $ 12.00K | $ 0.00 | |
| $ 0.00 | $ 4.00K | $ 77.00K | $ 12.00K | $ 0.00 | |
| $ 61.95M | $ 139.90M | $ 134.69M | $ 65.81M | $ 44.58M | |
| Depreciation and Amortization | $ 816.00K | $ 816.00K | $ 816.00K | $ 816.00K | $ 816.00K |
| $ -68.18M | $ -136.09M | $ -122.25M | $ -64.34M | $ -43.76M | |
| $ -61.95M | $ -139.90M | $ -134.62M | $ -65.81M | $ -44.58M | |
| $ -3.21M | $ 3.00M | $ 11.55M | $ 357.00K | $ -413.00K | |
| $ -65.17M | $ -136.91M | $ -123.07M | $ -65.45M | $ -44.99M | |
| $ -65.17M | $ -136.91M | $ -123.07M | $ -65.45M | $ -44.99M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.84 | $ -10.16 | $ -9.95 | $ -5.83 | $ -4.01 |
| Diluted EPS | $ -4.84 | $ -10.16 | $ -9.95 | $ -5.83 | $ -4.01 |
| Weighted Average Shares Outstanding | 13.47M | 13.47M | 12.36M | 11.23M | 11.23M |
| Weighted Average Shares Outstanding (Diluted) | 13.47M | 13.47M | 12.36M | 11.23M | 11.23M |
Currency in SEK